Assessment of driving performance in patients with relapsing-remitting multiple sclerosis during 24-month therapy with interferon beta-1a

被引：0
|
作者：
Stueckle, KF [1 ]
Sindern, E [1 ]
Kotterba, S [1 ]
机构：
[1] Univ Hosp Bergmannsheil, Bochum, Germany
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 50 条
  • [1] Interferon beta-1a in relapsing-remitting multiple sclerosis
    Blumhardt, L
    HOSPITAL MEDICINE, 1999, 60 (03): : 192 - 195
  • [2] Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
    Vazquez Gomez, Lazaro Aurelio
    Hidalgo Mesa, Carlos
    Broche Perez, Yunier
    Valdes Morales, Yanet
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2022, 20 (05): : 825 - 833
  • [3] Interferon beta-1a in relapsing-remitting multiple sclerosis: A meta-analysis
    Blumhardt, LD
    NEUROLOGY, 1999, 52 (06) : A498 - A498
  • [4] Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis
    Munschauer, FE
    Stuart, WH
    CLINICAL THERAPEUTICS, 1997, 19 (05) : 868 - 882
  • [5] Effects of statins on intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis
    Rudick, R.
    Pace, A.
    Panzara, M.
    Rani, S.
    Schrock, J.
    Calabresi, F.
    Confavreux, C.
    Galetta, S.
    Lublin, F.
    Radue, E. W.
    Stuart, W.
    Weinstock-Guttman, B.
    Wynn, D.
    MULTIPLE SCLEROSIS, 2007, 13 : S57 - S57
  • [6] Assessment of driving performance in patients with relapsing-remitting multiple sclerosis by a driving simulator
    Kotterba, S
    Orth, M
    Eren, E
    Fangerau, T
    Sindern, E
    EUROPEAN NEUROLOGY, 2003, 50 (03) : 160 - 164
  • [7] Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients
    Rudick, R. A.
    Kappos, L.
    Kinkel, R.
    Clanet, M.
    Phillips, J. T.
    Herndon, R. M.
    Sandrock, A. W.
    Munschauer, F. E., III
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (03) : 353 - 360
  • [8] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    VALUE IN HEALTH, 2019, 22 : S746 - S746
  • [9] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    VALUE IN HEALTH, 2019, 22 : S744 - S744
  • [10] Effect of Intramuscular Interferon beta-1a on Gray Matter Atrophy in Relapsing-Remitting Multiple Sclerosis
    Nakamura, Kunio
    Rudick, Richard
    Lee, Jar-Chi
    Foulds, Pamela
    Fisher, Elizabeth
    NEUROLOGY, 2010, 74 (09) : A407 - A407
12345